Categories AlphaGraphs, Earnings, Health Care
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company’s full-year net loss narrowed from the prior year.
Revenues increased 16% from last year to $11.45 million. As a result, the net loss attributable to Trxade Health narrowed to $3.47 million or $0.41 per share in fiscal 2022 from $5.32 million or $0.65 per share in the twelve months ended December 2021.
“I am pleased with the growth we have experienced in our Trxade platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Trxade’s stock has gained about 52% since the beginning of the year. The shares closed Monday’s regular trading session sharply higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Earnings Preview: Target (TGT) expected to report lower Q3 2025 sales and profit
Target Corporation (NYSE: TGT) is navigating a challenging retail landscape ahead of next week's earnings, as sales and margins face pressure from economic uncertainty and restrained consumer demand. With a
Home Depot (HD) expected to report higher revenue and earnings in Q3 2025
Shares of The Home Depot (NYSE: HD) dipped over 1% on Monday. The stock has dropped 5% in the past three months. The home improvement retailer is scheduled to report
Tyson Foods (TSN) Q4 2025 adj. earnings beat unexpectedly; sales up 2%
Tyson Foods, Inc. (NYSE: TSN), a leading processor and marketer of chicken, beef, and pork, reported stronger-than-expected earnings for the fourth quarter of fiscal 2025 when the company's sales rose
